Literature DB >> 9097953

Identification of a self-association region within the SCA1 gene product, ataxin-1.

E N Burright1, J D Davidson, L A Duvick, B Koshy, H Y Zoghbi, H T Orr.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by the expansion of a polyglutamine tract within the SCA1 gene product, ataxin-1. Expansion of this tract is believed to result in a gain of function by the mutant protein, perhaps through altered self-associations or interactions with other cellular proteins. We have used the yeast two hybrid system to determine if ataxin-1 is capable of multimerization. This analysis revealed that ataxin-1 does have the ability to self-associate, however, this association does not appear to be influenced by expansion of the polyglutamine tract. Consistent with this finding, deletion analysis excluded the involvement of the polyglutamine tract in ataxin-1 self-association, and instead localized the multimerization region to amino acids 495-605 of the wild type protein. These results, while identifying an ataxin-1 self-interaction region, fail to support a proposed model of polar-zipper mediated multimerization involving the ataxin-1 polyglutamine tract.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097953     DOI: 10.1093/hmg/6.4.513

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

2.  Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor.

Authors:  M I Diamond; M R Robinson; K R Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 3.  SCA1-phosphorylation, a regulator of Ataxin-1 function and pathogenesis.

Authors:  Harry T Orr
Journal:  Prog Neurobiol       Date:  2012-04-16       Impact factor: 11.685

4.  Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations.

Authors:  H B Clark; E N Burright; W S Yunis; S Larson; C Wilcox; B Hartman; A Matilla; H Y Zoghbi; H T Orr
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

Review 5.  Progress in pathogenesis studies of spinocerebellar ataxia type 1.

Authors:  C J Cummings; H T Orr; H Y Zoghbi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

6.  Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1.

Authors:  Akifumi Mizutani; Lei Wang; Harini Rajan; Parminder J S Vig; William A Alaynick; Joshua P Thaler; Chih-Cheng Tsai
Journal:  EMBO J       Date:  2005-08-25       Impact factor: 11.598

Review 7.  Clinical, genetic, molecular, and pathophysiological insights into spinocerebellar ataxia type 1.

Authors:  Antoni Matilla-Dueñas; Robert Goold; Paola Giunti
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

8.  Generation and characterization of LANP/pp32 null mice.

Authors:  Puneet Opal; Jesus J Garcia; Alanna E McCall; Bisong Xu; Edwin J Weeber; J David Sweatt; Harry T Orr; Huda Y Zoghbi
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

9.  Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua.

Authors:  Eunji Kim; Hsiang-Chih Lu; Huda Y Zoghbi; Ji-Joon Song
Journal:  Genes Dev       Date:  2013-03-15       Impact factor: 11.361

10.  Phosphorylation of S776 and 14-3-3 binding modulate ataxin-1 interaction with splicing factors.

Authors:  Cesira de Chiara; Rajesh P Menon; Molly Strom; Toby J Gibson; Annalisa Pastore
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.